Monitor Closely (1)pentobarbital will decrease the level or effect of buprenorphine subdermal implant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Monitor patients already on buprenorphine subdermal implant who require newly-initiated treatment with CYP3A4 inducer for signs and symptoms of withdrawal. If the porzione of the concomitant CYP3... https://mediasocially.com/story5240798/la-guida-pi%C3%B9-grande-per-ordinare-pentobarbital-di-sodio